A drug-injected psychosis can happen when someone takes an antipsychotic drug and takes their brain to a new place, researchers say.
The study of a drug called rimonabant, which is used to treat schizophrenia, found that it was linked to about a third of all patients with schizophrenia who reported psychotic episodes over the course of three years.
The drug is not used for long-term treatment of schizophrenia.
But rimonacarbazine (RIM) can cause psychosis in some patients.
Researchers from Imperial College London and the University of Oxford, led by Dr Ian McEwan, said the drug caused about three-quarters of the psychosis patients had experienced.
“What this suggests is that, in some of these patients, rimonabinol is having a significant impact on how they think and feel,” said McEwans team.
Dr McEwen said the new study would be important because it is the first to find the link between antipsychosis and schizophrenia.””
The next step would be to study whether it would be able to prevent some of the symptoms of schizophrenia.”
Dr McEwen said the new study would be important because it is the first to find the link between antipsychosis and schizophrenia.
“It’s a very rare and serious disease that affects people in very large numbers,” he said.
“Rimonabent, as it is currently marketed, is used in some hospitals to treat people with schizophrenia and is known to cause psychosis.”
There is a lot of evidence that it’s having an impact on people with this condition and so we need to look at how we might be able, through research, to reduce that impact.
“Rimo is currently prescribed to about 4,000 people with psychotic episodes.
The drug is a partial inhibitor of the antiparkinsonian drugs metoclopramide (MPP), clozapine (CZ-1), and olanzapine.
Rimoprofen and antipsychotics are the most commonly prescribed drugs for schizophrenia.
They are used to reduce the effects of psychotic episodes in patients with severe mental illness.
The new study found that antipsychos could reduce the risk of psychosis in patients taking rimonapristone.
But the researchers caution that antiparkiotics can cause serious side effects including anxiety and depression, and that antiprofessionals could have a similar effect.